BioMarin to Hold Virtual R&D Day at 11:00am ET Today
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) will host a virtual R&D Day on November 30, 2021, at 8:00 am PT.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) will host a virtual R&D Day on November 30, 2021, at 8:00 am PT. This event aims to inform the investment community about the company's earlier-stage development portfolio, focusing on innovative therapies for genetic diseases. External experts will join BioMarin's management to share insights on translating genetic discoveries into transformative medicines. The presentation will be accessible via YouTube, with a replay available on BioMarin's investor relations website.
Positive
- Focus on earlier-stage development portfolio aimed at rare genetic diseases.
- Involvement of external experts, enhancing credibility and insight.
Negative
- None.
Details
News Market Reaction – BMRN
The recorded move for BMRN in the trading session of this news was -1.27%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN RAFAEL, Calif., Nov. 30, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) will host a virtual R&D Day beginning at 8:00am PT/11:00am ET today, Tuesday, November 30, 2021. BioMarin management and external experts will provide an update to the investment community on the Company's earlier-stage development portfolio, which is focused on translating genetic discoveries into transformative medicines.
Video Webcast and Live Q&A
Interested parties may access the video presentation that will include audio and slides of the presentations via YouTube using this link: https://youtu.be/05iCxYehS-c. A replay of the meeting will be archived on BioMarin's IR web site.
About BioMarin
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare genetic diseases. The company's portfolio consists of seven commercialized products and multiple clinical and pre-clinical product candidates. For additional information, please visit www.biomarin.com. Information on such website is not incorporated by reference into this press release.
BioMarin® is a registered trademark of BioMarin Pharmaceutical Inc.
Contacts: | |
Investors | Media |
Traci McCarty | Debra Charlesworth |
BioMarin Pharmaceutical Inc. | BioMarin Pharmaceutical Inc. |
(415) 455-7558 | (415) 455-7451 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-hold-virtual-rd-day-at-1100am-et-today-301433892.html
SOURCE BioMarin Pharmaceutical Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.